NCE suit: 9-4 Amarin submitted a schedule for the Judge to hear oral arguments. FDA said it could be settled without oral arguments.
Nothing scheduled on the Judges calendar, yet.
The FDA isn't going to flat out win this...that's clear. What Amarin get's is unclear?
If AZN wants to start the long litigation battle, so be it. Amarin has enough claims to file to keep this in court until Vascepa's 2030 patents run out.
BB --------
AZN action picks up next week. Judge set to rule on releasing sealed docs before or on 9-11.
Yes, but no law suit of arbitrary and capricious actions leading to the malicious delay of exclusivity, Anchor, and REDUCEIT CVOT leading to X damages.
Market Data 
Markets 
AI
